About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,350 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,350 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2821-2840 of 3,350 trials

CompletedCP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior TherapyThis is a Phase 3, multi-national, open-label, 2-arm randomized study in patients with surgically incurable metastatic melanoma who have received no prior chemotherapy, or…NCT00257205·Huntsville, Alabama and 142 others

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

CompletedBevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by SurgeryRATIONALE: Drugs used in chemotherapy, such as temozolomide, paclitaxel albumin-stabilized nanoparticle formulation, and carboplatin, work in different ways to stop the growth of…NCT00626405·Anchorage, Alaska and 258 others

CompletedPhase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected MelanomaThis is a study of an investigational cancer vaccine called GRN-1201. Treatment with the GRN-1201 vaccine is a type of immunotherapy.NCT02696356·Cincinnati, Ohio and 3 others

TerminatedSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.This is a Phase 1, First-in-Human (FIH), open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics and preliminary…NCT05831995·San Francisco, California and 5 others

CompletedStudy of gp75 Vaccine in Patients With Stage III and IV MelanomaUp to 24 patients with stage III or stage IV melanoma will be enrolled. Patients who are currently disease-free but at high risk for relapse are also eligible.NCT00034554·New York, New York

TerminatedIntegrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®The purpose of the study is to demonstrate similar PK and efficacy and to show comparable safety and immunogenicity between JPB898, Opdivo-EU, and Opdivo-US, all administered in…NCT06587451·Santiago and 21 others

CompletedHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerRATIONALE: Hepatic arterial infusion uses a catheter to deliver anticancer substances directly into the liver.NCT00096083·Bethesda, Maryland

CompletedCMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node DiseaseThe purpose this research study is to determine if the combination of nivolumab and CMP-001 improves the likelihood of eradicating (destroying) disease in the lymph node…NCT03618641·Pittsburgh, Pennsylvania

TerminatedRituximab in Metastatic MelanomaThe purpose of this study is to determine whether rituximab as an adjuvant therapy in clinical stage IIIc / IV (no evidence of disease, AJCC (American Joint Committee on Cancer)…NCT01032122·Vienna

CompletedCharacteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the EsophagusBackground: Primary malignant melanoma of the esophagus (PMME) is a malignant tumor originating from esophageal melanocytes with a poor prognosis.NCT06291753·Guangzhou, Guangdong

UnknownEx Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive PharmacologySeveral studies conducted over the past decade have shown that Circulating tumor cells (CTCs) can be used as a marker for predicting disease progression and survival in patients…NCT03797053·Paris

CompletedVaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaRATIONALE: Vaccines made from DNA may help the body build an effective immune response to kill tumor cells.NCT00398073·New York, New York

CompletedAssessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOmaRecent studies suggest that patients with metastatic melanoma whose gut microbiome is colonized by eubiotic bacteria have a stronger anti-cancer response to anti CTLA-4 and anti…NCT04988841·Boulogne-Billancourt, Boulogne-Billancourt and 4 others

CompletedA Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in JapanThis is a medical chart review of ipilimumab treatment after nivolumab treatment in melanoma in JapanNCT03165422·Minato-ku, Tokyo

RecruitingA Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.This study, called NeoSenti, is exploring whether giving one dose of the immunotherapy drug pembrolizumab before surgery can help the immune system fight melanoma more effectively.NCT07448831·Jette, Brussels Capital

CompletedAldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic MelanomaThis randomized phase III trial studies aldesleukin with vaccine therapy to see how well it works compared to aldesleukin alone in treating patients with melanoma that has spread…NCT00019682·Birmingham, Alabama and 18 others

CompletedSodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersRATIONALE: Sodium stibogluconate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00498979·Cleveland, Ohio

CompletedS0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By SurgeryRATIONALE: Thalidomide may stop the growth of melanoma by blocking blood flow to the tumor.NCT00104988·Anchorage, Alaska and 131 others

Not yet recruitingInvestigating Participation Patterns Among Stage IV Melanoma PatientsClinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease.NCT06093594·San Francisco, California

CompletedSafety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsThis is a Phase I, open-label, dose-escalation trial in patients with advanced/metastatic solid tumors refractory to standard therapy; tumors may include malignant melanoma…NCT00625456·Billings, Montana and 3 others

PreviousPage 142 of 168Next